RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Laurel A. Eckhardt to Animals

This is a "connection" page, showing publications Laurel A. Eckhardt has written about Animals.
Connection Strength

0.367
  1. Peng C, Eckhardt LA. Role of the Igh intronic enhancer E? in clonal selection at the pre-B to immature B cell transition. J Immunol. 2013 Oct 15; 191(8):4399-411.
    View in: PubMed
    Score: 0.036
  2. Yan Y, Pieretti J, Ju Z, Wei S, Christin JR, Bah F, Birshtein BK, Eckhardt LA. Homologous elements hs3a and hs3b in the 3' regulatory region of the murine immunoglobulin heavy chain (Igh) locus are both dispensable for class-switch recombination. J Biol Chem. 2011 Aug 05; 286(31):27123-31.
    View in: PubMed
    Score: 0.030
  3. Li F, Yan Y, Pieretti J, Feldman DA, Eckhardt LA. Comparison of identical and functional Igh alleles reveals a nonessential role for E? in somatic hypermutation and class-switch recombination. J Immunol. 2010 Nov 15; 185(10):6049-57.
    View in: PubMed
    Score: 0.029
  4. Li F, Eckhardt LA. A role for the IgH intronic enhancer E mu in enforcing allelic exclusion. J Exp Med. 2009 Jan 16; 206(1):153-67.
    View in: PubMed
    Score: 0.026
  5. Yan Y, Park SS, Janz S, Eckhardt LA. In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3' regulatory region induces MYC expression at the immature stage of B cell development. Genes Chromosomes Cancer. 2007 Oct; 46(10):950-9.
    View in: PubMed
    Score: 0.023
  6. Zhang B, Alaie-Petrillo A, Kon M, Li F, Eckhardt LA. Transcription of a productively rearranged Ig VDJC alpha does not require the presence of HS4 in the IgH 3' regulatory region. J Immunol. 2007 May 15; 178(10):6297-306.
    View in: PubMed
    Score: 0.023
  7. Salas M, Eckhardt LA. Critical role for the Oct-2/OCA-B partnership in Ig-secreting cells. J Immunol. 2003 Dec 15; 171(12):6589-98.
    View in: PubMed
    Score: 0.018
  8. Shi X, Eckhardt LA. Deletional analyses reveal an essential role for the hs3b/hs4 IgH 3' enhancer pair in an Ig-secreting but not an earlier-stage B cell line. Int Immunol. 2001 Aug; 13(8):1003-12.
    View in: PubMed
    Score: 0.015
  9. Ong J, Stevens S, Roeder RG, Eckhardt LA. 3' IgH enhancer elements shift synergistic interactions during B cell development. J Immunol. 1998 May 15; 160(10):4896-903.
    View in: PubMed
    Score: 0.012
  10. Hines MD, Radomska HS, Eckhardt LA. Transcription factor effects on chromosome constitution of cell hybrids. Cytogenet Cell Genet. 1998; 83(1-2):64-72.
    View in: PubMed
    Score: 0.012
  11. Radomska HS, Eckhardt LA. Mammalian cell fusion in an electroporation device. J Immunol Methods. 1995 Dec 27; 188(2):209-17.
    View in: PubMed
    Score: 0.010
  12. Lieberson R, Ong J, Shi X, Eckhardt LA. Immunoglobulin gene transcription ceases upon deletion of a distant enhancer. EMBO J. 1995 Dec 15; 14(24):6229-38.
    View in: PubMed
    Score: 0.010
  13. Radomska HS, Hines MD, Eckhardt LA. Role of Oct-2 in immunoglobulin gene silencing. Ann N Y Acad Sci. 1995 Sep 29; 764:148-50.
    View in: PubMed
    Score: 0.010
  14. Radomska HS, Shen CP, Kadesch T, Eckhardt LA. Constitutively expressed Oct-2 prevents immunoglobulin gene silencing in myeloma x T cell hybrids. Immunity. 1994 Nov; 1(8):623-34.
    View in: PubMed
    Score: 0.010
  15. Shen L, Lieberman S, Eckhardt LA. The octamer/mu E4 region of the immunoglobulin heavy-chain enhancer mediates gene repression in myeloma x T-lymphoma hybrids. Mol Cell Biol. 1993 Jun; 13(6):3530-40.
    View in: PubMed
    Score: 0.009
  16. Eckhardt LA. Immunoglobulin gene expression only in the right cells at the right time. FASEB J. 1992 May; 6(8):2553-60.
    View in: PubMed
    Score: 0.008
  17. Lieberson R, Giannini SL, Birshtein BK, Eckhardt LA. An enhancer at the 3' end of the mouse immunoglobulin heavy chain locus. Nucleic Acids Res. 1991 Feb 25; 19(4):933-7.
    View in: PubMed
    Score: 0.007
  18. Porton B, Zaller DM, Lieberson R, Eckhardt LA. Immunoglobulin heavy-chain enhancer is required to maintain transfected gamma 2A gene expression in a pre-B-cell line. Mol Cell Biol. 1990 Mar; 10(3):1076-83.
    View in: PubMed
    Score: 0.007
  19. Bikoff EK, Eckhardt LA. Presentation of IgG2a antigens to class II-restricted T cells by stably transfected B lymphoma cells. Eur J Immunol. 1989 Oct; 19(10):1903-9.
    View in: PubMed
    Score: 0.007
  20. Yu H, Porton B, Shen LY, Eckhardt LA. Role of the octamer motif in hybrid cell extinction of immunoglobulin gene expression: extinction is dominant in a two enhancer system. Cell. 1989 Aug 11; 58(3):441-8.
    View in: PubMed
    Score: 0.007
  21. Zaller DM, Yu H, Eckhardt LA. Genes activated in the presence of an immunoglobulin enhancer or promoter are negatively regulated by a T-lymphoma cell line. Mol Cell Biol. 1988 May; 8(5):1932-9.
    View in: PubMed
    Score: 0.006
  22. Bikoff EK, Yu H, Eckhardt LA. T cell recognition of endogenous IgG2a expressed in B lymphoma cells. Eur J Immunol. 1988 Mar; 18(3):341-8.
    View in: PubMed
    Score: 0.006
  23. Yu H, Eckhardt LA. DNA rearrangement causes a high rate of spontaneous mutation at the immunoglobulin heavy-chain locus of a mouse myeloma cell line. Mol Cell Biol. 1986 Dec; 6(12):4228-35.
    View in: PubMed
    Score: 0.006
  24. Zhou J, Saleque S, Ermakova O, Sepulveda MA, Yang Q, Eckhardt LA, Schildkraut CL, Birshtein BK. Changes in replication, nuclear location, and expression of the Igh locus after fusion of a pre-B cell line with a T cell line. J Immunol. 2005 Aug 15; 175(4):2317-20.
    View in: PubMed
    Score: 0.005
  25. Zaller DM, Eckhardt LA. Deletion of a B-cell-specific enhancer affects transfected, but not endogenous, immunoglobulin heavy-chain gene expression. Proc Natl Acad Sci U S A. 1985 Aug; 82(15):5088-92.
    View in: PubMed
    Score: 0.005
  26. Eckhardt LA, Birshtein BK. Independent immunoglobulin class-switch events occurring in a single myeloma cell line. Mol Cell Biol. 1985 Apr; 5(4):856-68.
    View in: PubMed
    Score: 0.005
  27. Garrett FE, Emelyanov AV, Sepulveda MA, Flanagan P, Volpi S, Li F, Loukinov D, Eckhardt LA, Lobanenkov VV, Birshtein BK. Chromatin architecture near a potential 3' end of the igh locus involves modular regulation of histone modifications during B-Cell development and in vivo occupancy at CTCF sites. Mol Cell Biol. 2005 Feb; 25(4):1511-25.
    View in: PubMed
    Score: 0.005
  28. Eckhardt LA, Tilley SA, Lang RB, Marcu KB, Birshtein BK. DNA rearrangements in MPC-11 immunoglobulin heavy chain class-switch variants. Proc Natl Acad Sci U S A. 1982 May; 79(9):3006-10.
    View in: PubMed
    Score: 0.004
  29. Stevens S, Ong J, Kim U, Eckhardt LA, Roeder RG. Role of OCA-B in 3'-IgH enhancer function. J Immunol. 2000 May 15; 164(10):5306-12.
    View in: PubMed
    Score: 0.004
  30. Eckhardt LA, Herzenberg LA. Monoclonal antibodies to ThB detect close linkage of Ly-6 and a gene regulating ThB expression. Immunogenetics. 1980; 11(3):275-91.
    View in: PubMed
    Score: 0.003
  31. Choi JK, Shen CP, Radomska HS, Eckhardt LA, Kadesch T. E47 activates the Ig-heavy chain and TdT loci in non-B cells. EMBO J. 1996 Sep 16; 15(18):5014-21.
    View in: PubMed
    Score: 0.003
  32. Bergsagel PL, Timblin CR, Eckhardt L, Laskov R, Kuehl WM. Sequence and expression of a murine cDNA encoding PC326, a novel gene expressed in plasmacytomas but not normal plasma cells. Oncogene. 1992 Oct; 7(10):2059-64.
    View in: PubMed
    Score: 0.002
  33. Calza RE, Eckhardt LA, DelGiudice T, Schildkraut CL. Changes in gene position are accompanied by a change in time of replication. Cell. 1984 Mar; 36(3):689-96.
    View in: PubMed
    Score: 0.001
  34. Stanton LW, Yang JQ, Eckhardt LA, Harris LJ, Birshtein BK, Marcu KB. Products of a reciprocal chromosome translocation involving the c-myc gene in a murine plasmacytoma. Proc Natl Acad Sci U S A. 1984 Feb; 81(3):829-33.
    View in: PubMed
    Score: 0.001
  35. Tilley SA, Eckhardt LA, Marcu KB, Birshtein BK. Hybrid gamma 2b-gamma 2a genes expressed in myeloma variants: evidence for homologous recombination. Proc Natl Acad Sci U S A. 1983 Nov; 80(22):6967-71.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support